Blog

Killian Maudet: Honored to Attend ISMRC2025

Killian Maudet/LinkedIn

May 16, 2025, 05:40

Killian Maudet: Honored to Attend ISMRC2025

Killian Maudet, Alternance Data Scientist at Gustave Roussy, posted on LinkedIn:

“Last week, I had the opportunity to attend ISMRC2025 (International Symposium on Minimal Residual Cancer)in Nice. It was an incredibly enriching experience, both professionally and personally. I had the chance to explore the latest advances in liquid biopsy and to reflect on the future role of AI in this field.

I’d like to sincerely thank the organizers Klaus Pantel, Catherine Alix-Panabières, and Paul Hofman as well as all the speakers for the outstanding quality of this conference. I’m also grateful for the opportunity to present our team’s research during the ePoster session.

A special thank you to my supervisor Elsa Bernard and my school EFREI for making these experiences possible, and to my colleagues, especially Juliette Samaniego and Yoann Pradat, co-authors of this work.

Excited for the next edition!”

Further Reading: Highlights from The 14th International Symposium on Minimal Residual Cancer by Catherine Alix-Panabières

cancer Catherine Alix-Panabières EFREI Elsa Bernard ISMRC2025 Juliette Samaniego Killian Maudet Klaus Pantel OncoDaily Oncology Paul Hofman Yoann Pradat

Agenus Bets Big on Botensilimab

Carlos Rodriguez-Galindo: Childhood cancer has long been overlooked in global strategies - It is time to change that

EMBER-3 Trial Updates from ESMO Breast 2025: Imlunestrant Plus Abemaciclib Improves PFS in CDK4/6i-Pretreated ER+/HER2- Breast Cancer

Happy Birthday OncoDaily!

FDA Grants Accelerated Approval for Telisotuzumab Vedotin (EMRELIS™) in c-MET–Overexpressing Advanced Non-Small Cell Lung Cancer